These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 33221873)

  • 1. In vivo gradients of thalamic damage in paediatric multiple sclerosis: a window into pathology.
    De Meo E; Storelli L; Moiola L; Ghezzi A; Veggiotti P; Filippi M; Rocca MA
    Brain; 2021 Feb; 144(1):186-197. PubMed ID: 33221873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal Fluid-In Gradient of Cortical and Deep Gray Matter Damage in Multiple Sclerosis.
    Rubin M; Pagani E; Preziosa P; Meani A; Storelli L; Margoni M; Filippi M; Rocca MA
    Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200271. PubMed ID: 38896808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study.
    Zivadinov R; Hagemeier J; Bergsland N; Tavazzi E; Weinstock-Guttman B
    Eur J Neurol; 2018 Mar; 25(3):584-e36. PubMed ID: 29316038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous pathological processes account for thalamic degeneration in multiple sclerosis: Insights from 7 T imaging.
    Louapre C; Govindarajan ST; Giannì C; Madigan N; Sloane JA; Treaba CA; Herranz E; Kinkel RP; Mainero C
    Mult Scler; 2018 Oct; 24(11):1433-1444. PubMed ID: 28803512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
    Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced Quantitative MRI Unveils Microstructural Thalamic Changes Reflecting Disease Progression in Multiple Sclerosis.
    Cagol A; Ocampo-Pineda M; Lu PJ; Weigel M; Barakovic M; Melie-Garcia L; Chen X; Lutti A; Calabrese P; Kuhle J; Kappos L; Sormani MP; Granziera C
    Neurol Neuroimmunol Neuroinflamm; 2024 Nov; 11(6):e200299. PubMed ID: 39270143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping white matter damage distribution in neuromyelitis optica spectrum disorders with a multimodal MRI approach.
    Cacciaguerra L; Rocca MA; Storelli L; Radaelli M; Filippi M
    Mult Scler; 2021 May; 27(6):841-854. PubMed ID: 32672089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalamic white matter in multiple sclerosis: A combined diffusion-tensor imaging and quantitative susceptibility mapping study.
    Bergsland N; Schweser F; Dwyer MG; Weinstock-Guttman B; Benedict RHB; Zivadinov R
    Hum Brain Mapp; 2018 Oct; 39(10):4007-4017. PubMed ID: 29923266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Susceptibility Mapping of the Thalamus: Relationships with Thalamic Volume, Total Gray Matter Volume, and T2 Lesion Burden.
    Chiang GC; Hu J; Morris E; Wang Y; Gauthier SA
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):467-472. PubMed ID: 29371258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability.
    Carotenuto A; Cacciaguerra L; Pagani E; Preziosa P; Filippi M; Rocca MA
    Brain; 2022 Aug; 145(8):2785-2795. PubMed ID: 34919648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study.
    Bisecco A; Rocca MA; Pagani E; Mancini L; Enzinger C; Gallo A; Vrenken H; Stromillo ML; Copetti M; Thomas DL; Fazekas F; Tedeschi G; Barkhof F; Stefano ND; Filippi M;
    Hum Brain Mapp; 2015 Jul; 36(7):2809-25. PubMed ID: 25873194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.
    Gaetano L; Häring DA; Radue EW; Mueller-Lenke N; Thakur A; Tomic D; Kappos L; Sprenger T
    Neurology; 2018 Apr; 90(15):e1324-e1332. PubMed ID: 29540589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study.
    Zivadinov R; Bergsland N; Hagemeier J; Tavazzi E; Ramasamy DP; Durfee J; Cherneva M; Carl E; Carl J; Kolb C; Hojnacki D; Weinstock-Guttman B
    J Neurol Sci; 2018 Apr; 387():152-156. PubMed ID: 29571854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic and Extrinsic Mechanisms of Thalamic Pathology in Multiple Sclerosis.
    Mahajan KR; Nakamura K; Cohen JA; Trapp BD; Ontaneda D
    Ann Neurol; 2020 Jul; 88(1):81-92. PubMed ID: 32286701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White Matter Abnormalities in Multiple Sclerosis Evaluated by Quantitative Synthetic MRI, Diffusion Tensor Imaging, and Neurite Orientation Dispersion and Density Imaging.
    Hagiwara A; Kamagata K; Shimoji K; Yokoyama K; Andica C; Hori M; Fujita S; Maekawa T; Irie R; Akashi T; Wada A; Suzuki M; Abe O; Hattori N; Aoki S
    AJNR Am J Neuroradiol; 2019 Oct; 40(10):1642-1648. PubMed ID: 31515218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalamic damage and long-term progression of disability in multiple sclerosis.
    Rocca MA; Mesaros S; Pagani E; Sormani MP; Comi G; Filippi M
    Radiology; 2010 Nov; 257(2):463-9. PubMed ID: 20724544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Intracortical Lesions on Volumes of Subcortical Structures in Multiple Sclerosis.
    Kalinin I; Makshakov G; Evdoshenko E
    AJNR Am J Neuroradiol; 2020 May; 41(5):804-808. PubMed ID: 32381540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
    Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system.
    Kuchling J; Backner Y; Oertel FC; Raz N; Bellmann-Strobl J; Ruprecht K; Paul F; Levin N; Brandt AU; Scheel M
    Neuroimage Clin; 2018; 19():538-550. PubMed ID: 29984162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.